Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ferring Lægemidler A/S
A/S
Active
CVR 16313491
Amager Strandvej 405, 2770
Kastrup
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1992 · 33 years old
13 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Ferring Lægemidler A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
9M
7M
4M
2M
0M
2021: 7M
7M
2021
2022: 6M (-14% vs 2021)
6M
-14%
2022
2023: 7M (+17% vs 2022)
7M
+17%
2023
2024: 6M (-14% vs 2023)
6M
-14%
2024
2025: 7M (+17% vs 2024)
7M
+17%
2025
EBITDA
DKK millions
4M
3M
2M
1M
0M
2021: 3M
3M
2021
2022: 2M (-33% vs 2021)
2M
-33%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 3M (+50% vs 2024)
3M
+50%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
6.653
6.279
6.832
5.728
7.126
Staff expenses
-4.144
-4.143
-4.653
-3.713
-3.691
EBITDA
2.550
2.051
2.179
2.015
3.435
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
2.550
2.051
2.179
2.015
3.435
Net financials
-569
-315
-584
111
-147
Profit before tax
1.981
1.736
1.595
2.126
3.288
Tax
610
502
440
577
734
Net profit
1.371
1.234
1.155
1.549
2.554
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
38.757
38.147
41.514
35.918
36.695
Equity
11.229
9.858
8.624
11.969
10.420
Long-term debt
0
0
0
0
0
Short-term debt
24.039
23.839
29.256
23.949
26.275
Total debt
24.039
23.839
29.256
23.949
26.275
Financial ratios
5-year trend
EBITDA margin (of gross profit)
38,3 %
This company
2021
2025
Equity ratio
29,0 %
This company
38,2 %
Market median
This company
Market median
24% below market
2021
2025
Return on equity
12,2 %
This company
18,4 %
Market median
This company
Market median
34% below market
2021
2025
Net profit margin (of gross profit)
20,6 %
This company
2021
2025
Asset turnover (of gross profit)
0,17×
This company
2021
2025
Debt / equity
2,45×
This company
0,62×
Market median
This company
Market median
295% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ferring Lægemidler A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
